Intellia Therapeutics Ownership | Who Owns Intellia Therapeutics?
Intellia Therapeutics Ownership Summary
Intellia Therapeutics is owned by 95.18% institutional investors, 4.80% insiders, and 0.02% retail investors. Ark investment management is the largest institutional shareholder, holding 12.55% of NTLA shares. ARK Innovation ETF is the top mutual fund, with 8.90% of its assets in Intellia Therapeutics shares.
NTLA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Intellia Therapeutics | 95.18% | 4.80% | 0.02% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ark investment management | 13.02M | 12.55% | $122.11M |
Vanguard group | 10.19M | 10.09% | $118.82M |
Blackrock | 9.60M | 10.05% | $214.79M |
Blackrock funding, inc. /de | 10.03M | 9.67% | $94.05M |
State street | 4.36M | 4.57% | $97.64M |
Regeneron pharmaceuticals | 3.70M | 3.57% | $34.73M |
Sumitomo mitsui trust | 2.99M | 2.96% | $34.89M |
Baker bros. advisors lp | 2.68M | 2.58% | $25.10M |
Nikko asset management americas | 2.67M | 2.58% | $25.00M |
Morgan stanley | 2.34M | 2.45% | $52.32M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Discovery value fund | 561.56K | 3.76% | $6.55M |
Contrarius investment management | 1.92M | 2.68% | $42.87M |
Regeneron pharmaceuticals | 3.70M | 2.34% | $34.73M |
Ark investment management | 13.02M | 0.90% | $122.11M |
Orchard capital management | 79.21K | 0.82% | $742.97K |
Birchview capital, lp | 60.00K | 0.56% | $562.80K |
Himension capital (singapore) pte. | 729.42K | 0.53% | $6.84M |
Avidity partners management lp | 232.00K | 0.43% | $2.18M |
Granahan investment management | 913.62K | 0.35% | $8.57M |
Elmwood wealth management | 67.77K | 0.32% | $790.25K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baker bros. advisors lp | 2.68M | 0.24% | 2.03M |
Ubs group | 1.74M | 0.00% | 1.46M |
Goldman sachs group | 2.03M | 0.00% | 1.00M |
Two sigma advisers, lp | 2.00M | 0.05% | 970.70K |
Two sigma investments, lp | 1.84M | 0.05% | 863.36K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deep track capital, lp | - | - | -4.95M |
Capital investors | - | - | -3.78M |
Federated hermes | 3.85K | 0.00% | -2.74M |
Casdin capital | - | - | -2.00M |
Alliancebernstein | 265.32K | 0.00% | -1.93M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Graham capital management | 234.76K | 0.03% | 234.76K | $2.20M |
Avidity partners management lp | 232.00K | 0.43% | 232.00K | $2.18M |
Twinbeech capital lp | 137.76K | 0.03% | 137.76K | $1.29M |
Birchview capital, lp | 60.00K | 0.56% | 60.00K | $562.80K |
Dark forest capital management lp | 36.53K | 0.01% | 36.53K | $342.70K |
Sold Out
Holder | Change |
---|---|
Dinuzzo private wealth | -1.00 |
Global financial private client | -1.00 |
Richard w. paul & associates | -2.00 |
Jfs wealth advisors | -2.00 |
First pacific financial | -2.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 290 | -7.05% | 98,735,343 | -2.49% | 95 | 0.99% | 146 | -0.68% | 85 | -10.53% |
Mar 31, 2025 | 6 | -98.05% | 3,804,135 | -96.17% | 3 | 0.04% | 3 | -98.41% | 1 | -98.55% |
Dec 31, 2024 | 286 | -2.39% | 92,252,291 | -1.01% | 91 | 1.07% | 178 | 17.11% | 61 | -27.38% |
Sep 30, 2024 | 290 | -5.54% | 93,104,860 | 3.35% | 92 | 1.07% | 150 | -7.41% | 84 | -4.55% |
Jun 30, 2024 | 302 | 0.67% | 90,028,919 | -0.69% | 94 | 1.05% | 160 | 5.26% | 86 | -2.27% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
ARK Innovation ETF | 9.55M | 8.90% | 907.21K |
ARK Disruptive Innovation Full Composite | 8.71M | 8.11% | 966.00 |
American Funds SMALLCAP World A | 3.78M | 3.65% | 3.78M |
Vanguard US Total Market Shares ETF | 3.17M | 3.06% | 299.88K |
Vanguard Total Stock Mkt Idx Inv | 3.17M | 2.95% | -70.23K |
ARK Genomic Revolution ETF | 2.85M | 2.75% | -17.09K |
ARK Genomic Revolution | 2.88M | 2.68% | -220.20K |
Vanguard Small Cap Index | 2.51M | 2.34% | -16.78K |
iShares Russell 2000 ETF | 2.43M | 2.27% | -46.20K |
Nikko AM ARK Disruptive Innovation A USD | 1.76M | 1.70% | -68.46K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 20, 2025 | CHASE WILLIAM J | - | Buy | $1.00M |
Jul 23, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | Sell | $104.62K |
Jul 01, 2025 | Clark Eliana | EVP, Chief Technical Officer | Sell | $10.04K |
Jul 02, 2025 | Dube Michael P | VP, Chief Accounting Officer | Sell | $24.90K |
Jul 01, 2025 | GOODMAN JESSE | - | Sell | $14.28K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | 1 | 4 |
2025 Q2 | - | 2 |
2025 Q1 | - | 11 |
2024 Q4 | - | 1 |
2024 Q3 | - | 1 |
NTLA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools